The effect of autistic traits on response to and side-effects of pharmacological ADHD treatment in children with ADHD: results from a prospective clinical cohort

Table 3 Linear regression analysis

Coefficients
Explanatory variable	Unit of measurement	Unstandardized coefficinets			95% confidence interval forB
Explanatory variable	Unit of measurement	B	Std. error	Sjg.	Lower bound	Upper bound
Constant		13.565	5.463	.013	2.858	24.273
Total SNAP-IV score at baseline	Number	.545	.048	.000*	.451	.638
Non-ASD/ASD	Categorical (1 = non-ASD, 2 = ASD)	.695	1.993	.727	−3.211	4.601
ADHD medication	Categorical (0 = no, 1 = yes)	−5.130	2.637	.052	−10.298	.038
Gender	Categorical (1 = male, 2 = female)	1.638	1.725	0.342	−1.743	5.019
Age (year)		−.386	.271	.154	−.917	.145
	Number

Table displaying the relationship between the dependent outcome variable, SNAP IV score at 3 months, and ASD symptoms/Non-ASD symptoms, as independent variable. Adjusting for age, gender, and baseline SNAP-IV score
*Significant at .01; R² = .389

ISSN: 1866-1955